JCIC Asset Management Inc. Buys 145 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

JCIC Asset Management Inc. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,391 shares of the healthcare conglomerate’s stock after purchasing an additional 145 shares during the period. UnitedHealth Group accounts for approximately 2.8% of JCIC Asset Management Inc.’s portfolio, making the stock its 11th largest holding. JCIC Asset Management Inc.’s holdings in UnitedHealth Group were worth $6,660,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC boosted its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Swedbank AB bought a new stake in UnitedHealth Group during the 1st quarter valued at $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after acquiring an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $480,903,000. Finally, Dimensional Fund Advisors LP boosted its stake in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $564.48 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The stock has a market capitalization of $521.25 billion, a P/E ratio of 36.77, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The business’s 50 day simple moving average is $584.16 and its two-hundred day simple moving average is $536.49.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $6.56 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on UNH shares. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial reiterated a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, Barclays lowered their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.